Billy Wease LifeStyle Construction, Inc. – Trademark Portfolio
Entity Type: 03
Billy Wease LifeStyle Construction, Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include OPTIYOU RX. The owner is based in Gastonia, NC.
1614 W. Franklin Blvd.
Gastonia, NC 28052
Showing of trademarks Trademarks
Trademark Classifications
Billy Wease LifeStyle Construction, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Billy Wease LifeStyle Construction, Inc. have?
Billy Wease LifeStyle Construction, Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Billy Wease LifeStyle Construction, Inc. file in?
Billy Wease LifeStyle Construction, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Billy Wease LifeStyle Construction, Inc.'s most well-known trademarks?
Billy Wease LifeStyle Construction, Inc.'s registered trademark portfolio includes well-known marks such as OPTIYOU RX. These are among 1 currently registered trademark in the portfolio.
What is Billy Wease LifeStyle Construction, Inc.'s trademark registration success rate?
Billy Wease LifeStyle Construction, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.